FREE Case Review (866) 588-0600

Manufacturers File Lawsuit to Stop Sale of Generic Eliquis

The makers of Eliquis are suing Mylan Pharmaceuticals for alleged patent infringement on a generic version of their blood-thinning medication.

The makers of Eliquis (apixaban) are suing Mylan Pharmaceuticals for alleged patent infringement on a generic version of their blockbuster anticoagulant medication.

Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Eliquis side effects, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the Problem?

April 26, 2017 – Bristol-Myers Squibb (BMS) and Pfizer earlier this month filed a patent infringement lawsuit against Mylan Pharmaceuticals in the U.S. District Court for the District of Delaware.

Plaintiffs allege that Mylan, which is seeking approval to market 2.5 mg and 5 mg tablets of apixaban, is infringing on one patent owned by BMS and another owned by both BMS and Pfizer.

Apixaban is a blood thinner medication used to treat blood clots in the veins (thrombotic events). The drug is classified as a direct factor Xa inhibitor, and works by blocking the activity of clotting factor Xa, which prevents blood clots from developing or getting worse.

However, there is no antidote or reversal agent to stop the blood-thinning effects of Eliquis. This is why patients who take the drug may be at risk of developing life-threatening bleeding complications that may be irreversible.

Last month, Mylan notified BMS and Pfizer that it is seeking FDA approval to manufacture and sell apixaban, and had submitted an Abbreviated New Drug Application (ANDA) to the agency. Mylan asserted that its apixaban product would not infringe on the Eliquis patents, which Mylan claims are invalid and unenforceable.

In the lawsuit, BMS and Pfizer seek a judgment that their patents are not invalid or unenforceable and that Mylan’s manufacture and sale of its apixaban product will infringe on the Eliquis patents.

The lawsuit is: Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc., Case No. 1:17-cv-00379,US District Court for the District of Delaware.

Do I Have an Eliquis Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Eliquis lawsuits. We are handling individual litigation nationwide and currently accepting new bleeding injury cases in all 50 states.

Free Case Evaluation: Again, if you had bleeding or other serious side effects from Eliquis, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition